20 October 2026 Dear Shareholder 2026 Annual General Meeting - Notice of Meeting & Explanatory Statement, and Proxy Form Resonance Health Limited (ASX: RHT) (Company or Resonance Health) is holding its 2026 Annual General Meeting (AGM) on Thursday, 19 November 2026 at 10:00 am (AWST) at the...
Resonance Health: Notice of Annual General Meeting/Proxy Form
Filed with ASX · · 34 pages · English
Summary by 6ix AI
Resonance Health Ltd has issued a notice for its upcoming Annual General Meeting, detailing the agenda and resolutions to be voted on by shareholders. The meeting will cover the adoption of the remuneration report, election and re-election of directors, and approval for issuing securities under an incentive plan. Shareholders can vote in person or by proxy, with specific instructions provided for both methods of voting. The notice emphasizes the importance of shareholder participation and provides details on how to access the meeting materials electronically.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Earlier from Resonance Health
- Liver Fibrosis Device - Clinical Trial Results - Webinar
- AGM Date & Director Nomination Closing Date
- Change in Substantial Holding
- Global Strategic Alliance & MSA with Image Analysis Group
- Appendix 4G & Corporate Governance Statement
Later from Resonance Health
- Trading Halt
- Liver Fibrosis Device - EPoC Study Results
- $6.0 Million Placement Oversubscribed
- Proposed issue of securities - RHT
- Investor Presentation Liver Fibrosis Device & Capital Raise
Follow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health